AL
AlzChem Group AG
ALZCF · OTC
$184.90 +0.00% (+$0.00)
Market Cap 1.61B €
P/E Ratio 23.77x
Div. Yield 1.34%
ROE 26.10%
Bulios Fair Price
$123.82
33.0% downside
Current Price
$184.9
Undervalued Fair Value Overvalued
According to Bulios Fair Price, ALZCF is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
4/9Valuation
25 /100
Expensive PEG 1.47x
P/S 2.79x
P/B 5.98x
Growth
73 /100
Growing Rev. growth 1.20%
Book val. growth 21.17%
EPS growth 28.28%
Profitability
67 /100
Strong Net margin 11.72%
Op. margin 15.21%
FCF margin 3.23%
Quality
91 /100
Excellent ROE 26.10%
ROA 10.07%
Asset turnover 0.86x
Debt
100 /100
Low Current ratio 2.70x
Int. coverage 42.15x
Net debt/EBITDA 0.21x
Stability
80 /100
Stable Rev. volatility 1.41%
EPS volatility 23.11%
Profitable years 6
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about ALZCF
Online
Sector
Basic Materials
Industry
Chemicals - Specialty
CEO
Andreas Niedermaier
Employees
1,765
Headquarters
Trostberg
Upcoming events
29 OCT
Earnings
Upcoming earnings report